Xtant Medical Holdings (XTNT) Shares Outstanding (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Shares Outstanding (Entity) of $140.0 million for Q4 2025, up 0.71% year-over-year from $139.0 million in Q4 2024, and little changed quarter-over-quarter from $140.0 million in Q3 2025.
Xtant Medical Holdings (XTNT) Shares Outstanding (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Shares Outstanding (Entity) for 16 consecutive years, with $140.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 0.71% year-over-year to $140.0 million; the TTM figure through Dec 2025 stood at $140.0 million (up 0.71% YoY), while the FY2025 annual figure was $140.0 million, up 0.71% from the prior year.
- Shares Outstanding (Entity) was little changed at $140.0 million in Q4 2025 per XTNT's latest filing, from $140.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $140.0 million in Q4 2025 and bottomed at $86.7 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $115.4 million across 5 years, with a median of $119.3 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 555.7% — and 2022, when it advanced 0.7%.
- Xtant Medical Holdings' Shares Outstanding (Entity) stood at $87.1 million in 2021, then increased by 25.04% to $108.9 million in 2022, then climbed by 19.57% to $130.2 million in 2023, then grew by 6.81% to $139.0 million in 2024, then gained by 0.71% to $140.0 million in 2025.
- Business Quant data shows XTNT's Shares Outstanding (Entity) at $140.0 million in Q4 2025, $140.0 million in Q3 2025, and $139.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Xtant Medical Holdings | 45.04 Mn | 27.44 Mn | 17.75 Mn | 139.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 139.53 Mn |
| Sep 30, 2025 | 139.71 Mn |
| Jun 30, 2025 | 139.31 Mn |
| Mar 31, 2025 | 139.07 Mn |
| Dec 31, 2024 | 133.67 Mn |
| Sep 30, 2024 | 135.10 Mn |
| Jun 30, 2024 | 130.27 Mn |
| Mar 31, 2024 | 130.20 Mn |
| Dec 31, 2023 | 119.09 Mn |
| Sep 30, 2023 | 128.14 Mn |
| Jun 30, 2023 | 108.90 Mn |
| Mar 31, 2023 | 108.89 Mn |
| Dec 31, 2022 | 94.09 Mn |
| Sep 30, 2022 | 93.28 Mn |
| Jun 30, 2022 | 87.31 Mn |
| Mar 31, 2022 | 87.19 Mn |
| Dec 31, 2021 | 85.46 Mn |
| Sep 30, 2021 | 86.76 Mn |
| Jun 30, 2021 | 86.71 Mn |
| Mar 31, 2021 | 81.25 Mn |